# Short Duration High Intensity Intrapleural Alteplase With Pulmozyme in Pleural Infection Management

> **NCT04915586** · NA · COMPLETED · sponsor: **National University of Malaysia** · enrollment: 30 (actual)

## Conditions studied

- Loculated Empyema

## Interventions

- **DRUG:** Intra-pleural Alteplase 16mg with Pulmozyme (DNase) 5mg

## Key facts

- **NCT ID:** NCT04915586
- **Lead sponsor:** National University of Malaysia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-30
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2021-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04915586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04915586, "Short Duration High Intensity Intrapleural Alteplase With Pulmozyme in Pleural Infection Management". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04915586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*